Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 5;16(1):16.
doi: 10.1186/s12936-016-1651-5.

Malaria epidemiology in central Myanmar: identification of a multi-species asymptomatic reservoir of infection

Affiliations

Malaria epidemiology in central Myanmar: identification of a multi-species asymptomatic reservoir of infection

Isaac Ghinai et al. Malar J. .

Abstract

Background: The spread of artemisinin-resistant Plasmodium falciparum is a global health concern. Myanmar stands at the frontier of artemisinin-resistant P. falciparum. Myanmar also has the highest reported malaria burden in Southeast Asia; it is integral in the World Health Organization's plan to eliminate malaria in Southeast Asia, yet few epidemiological data exist for the general population in Myanmar.

Methods: This cross-sectional, probability household survey was conducted in Phyu township, Bago Region (central Myanmar), during the wet season of 2013. Interviewers collected clinical and behavioural data, recorded tympanic temperature and obtained dried blood spots for malaria PCR and serology. Plasmodium falciparum positive samples were tested for genetic mutations in the K13 region that may confer artemisinin resistance. Estimated type-specific malaria PCR prevalence and seroprevalence were calculated, with regression analysis to identify risk factors for seropositivity to P. falciparum. Data were weighted to account for unequal selection probabilities.

Results: 1638 participants were sampled (500 households). Weighted PCR prevalence was low (n = 41, 2.5%) and most cases were afebrile (93%). Plasmodium falciparum was the most common species (n = 19. 1.1%) and five (26%) P. falciparum samples harboured K13 mutations. Plasmodium knowlesi was detected in 1.0% (n = 16) and Plasmodium vivax was detected in 0.4% (n = 7). Seroprevalence was 9.4% for P. falciparum and 3.1% for P. vivax. Seroconversion to P. falciparum was 0.003/year in the whole population, but 16-fold higher in men over 23 years old (LR test p = 0.016).

Discussion: This is the first population-based seroprevalence study from central Myanmar. Low overall prevalence was discovered. However, these data suggest endemic transmission continues, probably associated with behavioural risk factors amongst working-age men. Genetic mutations associated with P. falciparum artemisinin resistance, the presence of P. knowlesi and discrete demographic risk groups present opportunities and challenges for malaria control. Responses targeted to working-age men, capable of detecting sub-clinical infections, and considering all species will facilitate malaria elimination in this setting.

Keywords: Artemisinin; Elimination; Malaria; Myanmar; Prevalence; Resistance; Risk factors; Serology; Transmission.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Study site with GPS points (circles) demarcating each village cluster
Fig. 2
Fig. 2
Proportion of Plasmodium species identified in a our sample and b WHO reporting for Myanmar. Pf, P. falciparum; Pv, P. vivax; Pk, P. knowlesi. K13 Pf samples with K13 mutations (not available for WHO statistics). * 1 × Pf Pv, 1 × Pk Pv, 1 × P. malariae
Fig. 3
Fig. 3
a Profile likelihood plot investigating the most likely age at which a change in seroconversion rate (SCR) occurs in P. falciparum serological data and b Seroprevalence curve fitted to P. falciparum with a change in SCR at age 23
Fig. 4
Fig. 4
Seroprevalence curves for P. falciparum a males and b females. The data for males has been fitted with two serconversion rates (SCR), with a change at age 23, and the data for females has been fitted with a constant SCR

References

    1. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet. 2012;379:413–431. doi: 10.1016/S0140-6736(12)60034-8. - DOI - PubMed
    1. WHO. Strategy for malaria elimination in the greater Mekong Sub region (2015–2030). Geneva: World Health Organization; 2015.
    1. WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2015. - PubMed
    1. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455–467. doi: 10.1056/NEJMoa0808859. - DOI - PMC - PubMed
    1. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411–423. doi: 10.1056/NEJMoa1314981. - DOI - PMC - PubMed

MeSH terms